By continuing to use Symptoma®, you confirm you accept the cookies. More on
493901 to 494000 most common queries
List represents a sample of symptoms, diseases, and other queries. Updated weekly.
Cheilitis granulomatosa: overview of 13 patients with long-term follow-up--results of management.
Molecular identification of Mycobacterium avium subspecies paratuberculosis in an Italian patient with Hashimoto's thyroiditis and Melkersson-Rosenthal syndrome.
Swelling and loss of photoreceptors in chronic human and experimental glaucomas.
Genetic basis of total colourblindness among the Pingelapese islanders.
Mutations in the cone photoreceptor G-protein alpha-subunit gene GNAT2 in patients with achromatopsia.
Canine CNGB3 mutations establish cone degeneration as orthologous to the human achromatopsia locus ACHM3.
Cone photoreceptor function loss-3, a novel mouse model of achromatopsia due to a mutation in Gnat2.
Mutations in the CNGB3 gene encoding the beta-subunit of the cone photoreceptor cGMP-gated channel are responsible for achromatopsia (ACHM3) linked to chromosome 8q21.
Rhodopsin measurement and dark-adaptation in a subject deficient in cone vision.
Gene therapy rescues cone function in congenital achromatopsia.
Total colourblindness is caused by mutations in the gene encoding the alpha-subunit of the cone photoreceptor cGMP-gated cation channel.
Molecular genetics of human blue cone monochromacy.
The spectral sensitivities of the middle- and long-wavelength-sensitive cones derived from measurements in observers of known genotype.
Gene therapy for red-green colour blindness in adult primates.
Organization of the human trichromatic cone mosaic.
Restoration of cone vision in a mouse model of achromatopsia.
Functional photoreceptor loss revealed with adaptive optics: an alternate cause of color blindness.
Linkage relationship of a cloned DNA sequence on the short arm of the X chromosome to Duchenne muscular dystrophy.
The molecular basis of visual excitation.
Molecular basis of visual excitation.
Molecular genetics of inherited variation in human color vision.
anemia, fatigue, bone pain, renal blood, fatty liver, weight gain, benign nodules , jaundice, leukocytosis, fever, pallor, chronic pain, liver tenderness, skin pigmentation, edema
In search of a selective antiviral chemotherapy.
Characterization of age- and dose-related outcomes of duck hepatitis B virus infection.
John Richard Graybill
Transfer of hepatitis B virus genome by adenovirus vectors into cultured cells and mice: crossing the species barrier.
A new avian hepadnavirus infecting snow geese (Anser caerulescens) produces a significant fraction of virions containing single-stranded DNA.
Single-cell analysis of covalently closed circular DNA copy numbers in a hepadnavirus-infected liver.
anemia, fatigue, bone pain, renal blood, fatty liver, weight gain, benign nodules , jaundice, leukocytosis, fever, pallor, chronic pain, liver tenderness, skin pigmentation
In vitro model for the nuclear transport of the hepadnavirus genome.
Susceptibility to duck hepatitis B virus infection is associated with the presence of cell surface receptor sites that efficiently bind viral particles.
brain fog, fatigue, chronic tension headache,
Evidence that hepatocyte turnover is required for rapid clearance of duck hepatitis B virus during antiviral therapy of chronically infected ducks.
A new group of hepadnaviruses naturally infecting orangutans (Pongo pygmaeus).
Duck hepatitis B virus: an invaluable model system for HBV infection.
A splice hepadnavirus RNA that is essential for virus replication.
anemia, fatigue, bone pain, renal blood, fatty liver, weight gain, benign nodules , jaundice, leukocytosis, fever, pallor, chronic pain, liver tenderness
Low dynamic state of viral competition in a chronic avian hepadnavirus infection.
Avian hepatitis B virus infection is initiated by the interaction of a distinct pre-S subdomain with the cellular receptor gp180.
Occult lifelong persistence of infectious hepadnavirus and residual liver inflammation in woodchucks convalescent from acute viral hepatitis.
Molecular events in the pathogenesis of hepadnavirus-associated hepatocellular carcinoma.
The half-life of duck hepatitis B virus supercoiled DNA in congenitally infected primary hepatocyte cultures.
Hepatocyte turnover during resolution of a transient hepadnaviral infection.
Kinetics of duck hepatitis B virus infection following low dose virus inoculation: one virus DNA genome is infectious in neonatal ducks.
anemia, fatigue, bone pain, renal blood, fatty liver, weight gain, benign nodules , jaundice, leukocytosis, fever, pallor, chronic pain
Hepadnavirus infection requires interaction between the viral pre-S domain and a specific hepatocellular receptor.
Viral and cellular determinants involved in hepadnaviral entry.
Comparison of preseptal and pretarsal injections of botulinum toxin in the treatment of blepharospasm and hemifacial spasm.
Botulinum toxin A treatment for primary hemifacial spasm: a 10-year multicenter study.
Beneficial effects of botulinum toxin type a for patients with painful tic convulsif.
An attempt to relieve hemifacial spasm by neurolysis of the facial nerves; a report of two cases of hemifacial spasm with reflections on the nature of the spasm, the contracture and mass movement.
Review of the FDA-approved uses of botulinum toxins, including data suggesting efficacy in pain reduction.
Hemifacial spasm and involuntary facial movements.
DYSBOT: a single-blind, randomized parallel study to determine whether any differences can be detected in the efficacy and tolerability of two formulations of botulinum toxin type A--Dysport and Botox--assuming a ratio of 4:1.
The many faces of hemifacial spasm: differential diagnosis of unilateral facial spasms.
anemia, fatigue, bone pain, renal blood, fatty liver, weight gain, benign nodules , jaundice, leukocytosis, fever, pallor
Psychiatric disorders in adult-onset focal dystonia: a case-control study.
Prognostic value of the lateral spread response for intraoperative electromyography monitoring of the facial musculature during microvascular decompression for hemifacial spasm.
Long-term botulinum toxin efficacy, safety, and immunogenicity.
Health-related quality of life and psychosocial characteristics of patients with benign essential blepharospasm.
Tactile temporal discrimination in patients with blepharospasm.
Abnormal perception of vibration-induced illusion of movement in dystonia.
Hemifacial spasm: clinical findings and treatment.
Abnormal plasticity of sensorimotor circuits extends beyond the affected body part in focal dystonia.
Compression syndromes caused by substernal goitres.
Acute respiratory failure and tracheal obstruction in patients with intrathoracic goiter.
Surgical management of substernal goitre.
Surgical management of substernal goiters: clinical experience of 170 cases.
Surgical aspects of 175 mediastinal goiters.
Morbidity and mortality of thyroidectomy for substernal goiter.
anemia, fatigue, bone pain, renal blood, fatty liver, weight gain, benign nodules , jaundice, leukocytosis, fever
Low-attenuation mediastinal masses on CT.
Substernal goiter: a clinical review.
Parathyroid preservation during thyroid surgery.
Goiters and airway problems.
Benign superior vena cava syndrome.
Rationale for the operative management of substernal goiters.
EXPERIENCE WITH MEDIASTINOSCOPY.
Thyroidectomy in patients with marked thyroid enlargement: airway management, morbidity, and outcome.
Evidence-based surgical management of substernal goiter.
Increasing incidence of thyroid cancer is due to increased pathologic detection.
Primary mediastinal tumors. Part 1: tumors of the anterior mediastinum.
Vestibulocochlear Nerve Injuries
Hematoma, Epidural, Spinal
Deep brain stimulation in chorea acanthocytosis.
Chorein-sensitive polymerization of cortical actin and suicidal cell death in chorea-acanthocytosis.
Computational identification of phospho-tyrosine sub-networks related to acanthocyte generation in neuroacanthocytosis.
A neuropathological study of autosomal-dominant chorea-acanthocytosis with a mutation of VPS13A.
Cardiac and neurologic involvement in McLeod syndrome.
Novel pathogenic mutations and copy number variations in the VPS13A gene in patients with chorea-acanthocytosis.
Identification and characterization of a novel XK splice site mutation in a patient with McLeod syndrome.
Evolution of striatal degeneration in McLeod syndrome.
Development of mesial temporal lobe epilepsy in chorea-acanthocytosis.
Characteristic head drops and axial extension in advanced chorea-acanthocytosis.
Cardiac abnormalities in McLeod syndrome.